# Kyle Coleman, M.D. – FDA Inspection, Mar 20, 2019

Source: https://www.keypedia.com/records/fda_inspections/kyle-coleman-md/2861d6c2-ffc8-4ca5-822a-a77e8083fbc7
Source feed: FDA_Inspections

> FDA inspection 1084927 of Kyle Coleman, M.D., March 20, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1084927
- Company Name: Kyle Coleman, M.D.
- Inspection Date: 2019-03-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [Company Rep](https://www.keypedia.com/people/laura-l-staples/fe59bc9c-b439-4dd8-8c8a-5fac6f7733f8)

Company: https://www.keypedia.com/companies/kyle-coleman-md/b756ec84-f915-4849-a733-6953a7bdc43a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
